Tag: EMA

March 6, 2017 Off

Amryt on track with skin treatment for butterfly children

By Dino Mustafić

Amryt is on track to begin the phase 3 trial at the end of March for its new skin healing treatment in an orphan disease, with regulatory authority discussions now completed with Food and Drug Administration (FDA) and European Medicines Agency (EMA) and the design of the clinical trial established.